Diamyd Medical
Phase 3Diamyd Medical is a Swedish clinical-stage diabetes company active in the field of pharmaceutical development. The share is listed on Nasdaq Stockholm First North (ticker: DMYD B).
Founded
1994
Focus
Biologics
About
Diamyd Medical is a Swedish clinical-stage diabetes company active in the field of pharmaceutical development. The share is listed on Nasdaq Stockholm First North (ticker: DMYD B).
Funding History
5Total raised: $67.2M
PIPE$12MUndisclosedSep 15, 2019
Grant$5MEuropean UnionJun 15, 2012
Series B$25MUndisclosedJun 15, 2008
Series A$15MUndisclosedJun 15, 2005
Company Info
TypePrivate
Founded1994
LocationStockholm, Sweden
StagePhase 3
Contact
Sectors
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile